New Haven Biz reported on the keynote presenter at the 2019 Marcum New England Life Science & Biotech Summit. John L. LaMattina, a former Pfizer executive.
New Haven Biz
By Natalie Missakian
Meanwhile, LaMattina rejected critics’ assertion that the pharmaceutical industry is “obscenely profitable.” He said metrics such as return on equity show the drug industry is somewhere “in the middle” when it comes to profitability, behind other sectors such as computer sciences and the beverage industry.
“I don’t see an industry that’s profiteering,” he said. “I see an industry that’s taking its resources and investing in the high-risk business called innovation.”